CICOF(CICOF)
CICOF
No analyst ratings available
No analyst price targets available for CICOF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E | FY2028E |
|---|---|---|---|
| Revenue Avg | $230.95B | $222.81B | $229.86B |
| Low | $222.74B | $200.69B | $214.40B |
| High | $241.08B | $243.33B | $245.46B |
| EBITDA Avg | $86.23B | $83.19B | $85.82B |
| Low | $83.16B | $74.93B | $80.05B |
| High | $90.01B | $90.85B | $91.65B |
| EBIT Avg | $68.78B | $66.35B | $68.45B |
| Low | $66.33B | $59.77B | $63.85B |
| High | $71.79B | $72.46B | $73.10B |
| Net Income Avg | $25.35B | $19.82B | $18.74B |
| Low | $23.14B | $18.09B | $17.10B |
| High | $27.59B | $21.57B | $20.39B |
| EPS Avg | $1.63 | $1.27 | $1.20 |
| Low | $1.49 | $1.16 | $1.10 |
| High | $1.77 | $1.39 | $1.31 |
| Analysts (Rev / EPS) | 8 / 1 | 9 / 1 | 3 / 1 |
| Metric | Q3 2026 |
|---|---|
| Revenue Avg | $55.10B |
| Low | $53.25B |
| High | $56.96B |
| EBITDA Avg | $20.57B |
| Low | $19.88B |
| High | $21.27B |
| EBIT Avg | $16.41B |
| Low | $15.86B |
| High | $16.96B |
| Net Income Avg | — |
| Low | — |
| High | — |
| EPS Avg | — |
| Low | — |
| High | — |
| Analysts (Rev / EPS) | 2 / — |